Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245048 · ClinicalTrials.gov registry record
CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 73
- Enrollment target
NCT02245048: Completed study, sponsored by Mayo Clinic.
NCT02245048 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02245048 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if carotid artery ultrasound scanning can provide additional information for determining cardiovascular risk in patients. Patients who agree to participate wil undergo non-invasive carotid intima-media thickness (CIMT) measurement and plaque assessment. Findings of CIMT will be compared to results of patient standard of care stress echocardiogram (SE) and of diastolic function. We hypothesize tht 1) in patients undergoing SE for inappropriate or uncertain indications, CIMT and plaque assessment will provide useful risk stratification beyond use of traditional risk factors; 2) CIMT findings will correlate with results of SE in terms of exercise capacity and 3) Exercise capacity will correlate with diastolic function.
Primary Outcome
We are comparing the % of patients with abnormal IMT defined as presence of plaque (= or \>1.5mm) or CIMT \>75% percentile for age, race, and gender compared to % of patients with positive ischemia on stress echocardiogram as defined by a new wall motion abnormality on echocardiogram with stress.
Interventions
- OTHER Carotid Intima-Media Thickness (CIMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-05 |
What the finished NCT02245048 record still lists
NCT02245048 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Carotid Intima-Media Thickness (CIMT) is the first listed.
NCT02245048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02245048 about?
NCT02245048 is a clinical study titled "CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification". The purpose of this research study is to determine if carotid artery ultrasound scanning can provide additional information for determining cardiovascular risk in patients. Patients who agree to participate wil undergo non-invasive carotid intima-media thickness (CIMT) measurement and plaque assess...
What is the current status of trial NCT02245048?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02245048?
The interventions under investigation include: Carotid Intima-Media Thickness (CIMT) (OTHER).
Who is sponsoring clinical trial NCT02245048?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia